A randomized, open-label phase II study of AZD4547 (AZD) versus Paclitaxel in previously treated patients with advanced gastric cancer (AGC) with Fibroblast Growth Factor Receptor 2 (FGFR2) polysomy or gene amplification: SHINE study

Yung-Jue Bang, E. Van Cutsem, W Mansoor, Russell Petty, Y. Chao, David Cunningham, David Ferry, Donal Landers, Paul K. Stockman, N Smith, C Geh, Elaine Kilgour

    Research output: Contribution to journalArticle

    Original languageEnglish
    JournalJournal of Clinical Oncology
    Volume33
    Issue number15
    Publication statusPublished - 31 Jan 2017

    Cite this